Abbott Labs Wins FDA Approval For MitraClip Implant

Law360, New York (October 25, 2013, 5:35 PM ET) -- Abbott Laboratories won the green light from U.S. medical device regulators for its MitraClip implantable heart device, which is marketed as a less invasive way to treat heart valve defects, the health care products giant said Friday. 

The U.S. Food and Drug Administration has approved the MitraClip treatment, which would be among of the first of its kind of device sold in the U.S., for patients with serious mitral regurgitation — a health condition where the mitral valve doesn't fully close — and for whom surgery...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required